bioAffinity Technologies, Inc. (BIAF)
6.055
-0.09
(-1.46%)
USD |
NASDAQ |
Oct 02, 16:00
6.06
0.00 (0.00%)
Pre-Market: 20:00
bioAffinity Technologies EPS Diluted (Quarterly) : -9.660 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -9.660 |
| March 31, 2026 | -12.12 |
| December 31, 2025 | -10.46 |
| September 30, 2025 | -71.05 |
| June 30, 2025 | -76.07 |
| March 31, 2025 | -73.64 |
| December 31, 2024 | -92.31 |
| September 30, 2024 | -72.66 |
| June 30, 2024 | -83.38 |
| March 31, 2024 | -89.03 |
| December 31, 2023 | -115.51 |
| September 30, 2023 | -118.54 |
| Date | Value |
|---|---|
| June 30, 2023 | -91.90 |
| March 31, 2023 | -81.79 |
| December 31, 2022 | -89.91 |
| September 30, 2022 | -264.50 |
| June 30, 2022 | -5.373 |
| March 31, 2022 | -89.79 |
| December 31, 2021 | -340.16 |
| September 30, 2021 | -92.34 |
| June 30, 2021 | 90.30 |
| March 31, 2021 | -43.68 |
| December 31, 2020 | -130.31 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Veracyte, Inc. | 0.3106 |
| Quantum Cyber NV | -0.4307 |
| MediciNova, Inc. | -0.047 |
| ADMA Biologics, Inc. | 0.1642 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.366M |
| Revenue (Quarterly) | 1.511M |
| Total Expenses (Quarterly) | 4.877M |
| Enterprise Value | 1.743M |
| Gross Profit Margin (Quarterly) | 23.91% |
| Profit Margin (Quarterly) | -222.8% |
| Earnings Yield | -1.71K% |
| Normalized Earnings Yield | -1259.06 |